Who Should Not Take Bacopa Monnieri

Bacopa monnieri is often perceived as a "simple herb for memory" that anyone can take. However, any substance with real biological activity has limitations. For bacopa they are linked to its cholinergic and sedative action, its effect on the digestive tract and potential interactions with medications. Our editorial team has systematized who should refrain from taking it and who should first talk to a doctor.
Absolute and relative limitations
For most plant supplements, including bacopa, there are no official medical contraindications approved by regulators in the form of a drug package insert - they are sold as dietary supplements. Therefore the list of limitations is formed on the basis of clinical studies, known mechanisms of action and the general principle of caution.
Conditionally, they can be divided into two groups. The first includes situations where taking it without a doctor is inadvisable due to a lack of safety data or high potential risk: pregnancy, breastfeeding, childhood, a known allergy to the plant. The second includes conditions in which bacopa may be acceptable but requires a specialist's assessment and monitoring: chronic diseases and constant medication use.
It is important to remember: the absence of reports of harm does not equal proven safety. Most bacopa studies lasted up to three months and included relatively healthy adults. People with serious diseases were, as a rule, excluded from such studies.
That is why our editorial team considers contraindications more broadly than the "official" minimum and advises consulting a doctor in all situations where risk cannot be ruled out. Below we examine each group in detail.
Pregnancy, breastfeeding and childhood
Data on bacopa's safety during pregnancy in humans are absent. No controlled clinical studies have been conducted in pregnant women, and they are unlikely to be conducted for ethical reasons. The potential effect on the hormonal system (in particular on the thyroid gland in animal experiments) and the unknown effect on the fetus are weighty arguments in favor of avoiding intake.
The situation is similar with breastfeeding: it is unknown whether bacosides pass into breast milk and in what amount. In the absence of data, standard medical practice is to refrain from over-the-counter herbal remedies during this period unless there is a clear need.
Regarding children and adolescents the picture is somewhat different. Bacopa was traditionally given to children in India, and several studies in this age group have been conducted. The systematic review by Kean et al. (2016) analyzed these works and concluded that the data are limited and inconsistent, and that higher-quality studies are needed for reliable conclusions.
Therefore our editorial team does not recommend giving bacopa to children and adolescents on your own - only after consulting a pediatrician or a pediatric neurologist, especially when it comes to problems with attention or learning. Such conditions require a full diagnosis, not a random selection of supplements.

Conditions requiring caution
Next is a list of conditions in which taking bacopa is not categorically forbidden but requires discussion with a doctor because of possible symptom aggravation or an effect on treatment.
| Condition | Why caution is needed |
|---|---|
| Stomach ulcer, gastritis, GERD | Saponins irritate the mucosa, frequent stomach side effects (Morgan, Stevens, 2010) |
| Irritable bowel syndrome, inflammatory bowel disease | Faster peristalsis may provoke a flare-up |
| Bradycardia, cardiac conduction disorders | Theoretical cholinergic effect on heart rate |
| Bronchial asthma, COPD | Cholinergic activity may theoretically affect bronchial tone |
| Thyroid diseases | In animals the extract changed thyroxine levels |
| Urinary retention, urinary tract obstruction | Theoretical effect of cholinergic mechanisms |
Some of these cautions are based not on clinical cases but on known mechanisms of action - the cholinergic activity of bacopa described in preclinical works (Aguiar, Borowski, 2013; Russo, Borrelli, 2005). However, for a person with heart disease or asthma, even a theoretical risk is sufficient reason to consult.
Planned surgery deserves separate mention. Because of the potential sedative effect and possible interactions with anesthesia drugs, most surgeons recommend stopping herbal supplements in advance, usually at least two weeks. Be sure to tell the anesthesiologist about all the supplements you take.
People with severe liver or kidney disease should also refrain from taking it on their own: any plant substances are metabolized and eliminated through these organs, and there are no data on such patients.
Interactions with medications
The second large group of limitations is constant use of medications. There are few systematic clinical studies of bacopa's interactions with drugs, so the vast majority of cautions are based on mechanisms of action and laboratory data.
- Sedatives, sleeping pills, alcohol.Possible enhancement of drowsiness and sluggishness.
- Drugs affecting acetylcholine.Cholinesterase inhibitors (for example, in dementia) and anticholinergic agents - a theoretical strengthening or weakening of their action is possible.
- Thyroid drugs.Levothyroxine and antithyroid drugs - a change in hormonal balance is possible; monitoring of tests is needed.
- Drugs that slow the pulse.Beta-blockers, some antiarrhythmics - a theoretical additive effect.
- Drugs with a narrow therapeutic window.Anticonvulsants, anticoagulants, immunosuppressants - because of a possible effect on liver enzymes described in laboratory models.
- Antidepressants.Bacopa affects the serotonergic system in preclinical models; the combination should be discussed with a doctor.
This does not mean that bacopa is guaranteed to harm people who take such drugs. But it is precisely in these situations that the risk of an unpredictable interaction is highest, and the consequences can be serious. A doctor can assess the advisability of the supplement and, if necessary, prescribe additional monitoring.
Pay attention to combination supplements too. If bacopa is part of a nootropic complex along with other plants, the number of potential interactions grows, and assessing them becomes even harder.
How to act if you are in a risk group
Falling into one of the listed groups does not always mean a complete ban. It is a signal for considered decisions and a conversation with a doctor, not for independent experiments.
Before the consultation, prepare a full list of the medications and supplements you take, as well as the name of the specific bacopa product with its dosage. This makes it easier for the doctor to assess the risks and give a practical answer.
If the doctor has no objection, it is reasonable to start with a minimal dose, take the supplement with food and, during the first weeks, carefully monitor how you feel. For patients with thyroid diseases, a follow-up hormone test after a few weeks may be advisable.
Stop taking it immediately and see a doctor if a marked slowing of the pulse, dizziness, shortness of breath, a rash, severe abdominal pain or other unusual symptoms appear.
And finally, remember that a decline in memory or concentration can itself be a symptom of a disease - from vitamin B12 deficiency and thyroid dysfunction to depression. A supplement should not delay diagnosis.
Editorial conclusions
Bacopa monnieri is not a herb that is "safe for everyone." Pregnant and breastfeeding women, children and adolescents without a doctor's recommendation, and people with an allergy to the plant should refrain from taking it on their own.
Caution and consultation are needed for diseases of the gastrointestinal tract, heart, respiratory system and thyroid gland, as well as for constant use of sedative, cholinergic, thyroid and cardiac drugs.
The right decision in doubtful cases is to discuss the supplement with a doctor rather than rely on reviews from the internet.
We also recommend reading "Side Effects of Bacopa Monnieri," "Myths About Bacopa Monnieri" and "What to Combine Bacopa Monnieri With."
References
- Aguiar S, Borowski T. Neuropharmacological review of the nootropic herb Bacopa monnieri. Rejuvenation Res. 2013;16(4):313–326.
- Russo A, Borrelli F. Bacopa monniera, a reputed nootropic plant: an overview. Phytomedicine. 2005;12(4):305–317.
- Morgan A, Stevens J. Does Bacopa monnieri improve memory performance in older persons? Results of a randomized, placebo-controlled, double-blind trial. J Altern Complement Med. 2010;16(7):753–759.
- Kean JD, Downey LA, Stough C. A systematic review of the Ayurvedic medicinal herb Bacopa monnieri in child and adolescent populations. Complement Ther Med. 2016;29:56–62.
- Pase MP, Kean J, Sarris J, et al. The cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trials. J Altern Complement Med. 2012;18(7):647–652.
- Saper RB, Kales SN, Paquin J, et al. Heavy metal content of ayurvedic herbal medicine products. JAMA. 2004;292(23):2868–2873.
Andriy Melnyk
A strength-sports coach and author of programs for beginner and intermediate levels. Writes about training planning.


